137 VENTURES MANAGEMENT, LLC

Thesis

137 Ventures Management, LLC, established in 2011 and based in San Francisco, is a venture capital and private equity firm that provides customized liquidity solutions and structured transactions to founders, executives, early investors, and employees of high-growth private technology companies. Their investment thesis centers on building concentrated, long-term positions in generational technology companies, primarily within the United States but with an expanding global scope. The firm employs a flexible capital approach, specializing in structured liquidity offerings, direct secondaries, and primary financings, offering alternatives to traditional secondary markets. They also engage in equity loans and tender offers. Their investment sectors are broad, historically including Software, IT, TMT, Media, Business Solutions, FinTech, HealthTech, Medical Devices, DeepTech, Healthcare, Investment Management, and Consumer. More recently, their focus has shifted towards AI, defense, advanced industrials, frontier tech, HR Tech, Consumer, Defense Tech, Logistics, and SaaS. 137 Ventures typically invests in Series A through C, growth-stage, and late-stage companies, though some sources indicate a preference for Seed and Series A. As of April 2026, the firm manages over $15 billion in AUM, having recently closed over $700 million across two new funds. Typical check sizes range from $5 million to $30 million, with a sweet spot around $15 million for Seed stage.

Related lists

• Seed-stage AI investors
• Seed-stage Enterprise investors
• Seed-stage Fintech investors